Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics, Pharmacodynamics,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06365437
What this trial is testing

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 33
Early research (Phase 1)Ended earlyNCT03140072
What this trial is testing

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

Who this might be right for
Asthma
AstraZeneca 34
Testing effectiveness (Phase 2)Ended earlyNCT05580770
What this trial is testing

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 23
Early research (Phase 1)Study completedNCT01044537
What this trial is testing

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04075266
What this trial is testing

Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)UnknownNCT06114329
What this trial is testing

Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Who this might be right for
Fabry Disease
AceLink Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395
What this trial is testing

Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Actuate Therapeutics Inc. 100
Early research (Phase 1)Study completedNCT05966324
What this trial is testing

Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population

Who this might be right for
Hypertension
AstraZeneca 41
Early research (Phase 1)Ended earlyNCT06159062
What this trial is testing

A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B Virus Infection
Yangshengtang Co., Ltd 1
Early research (Phase 1)Study completedNCT06004180
What this trial is testing

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)

Who this might be right for
Parkinson Disease
H. Lundbeck A/S 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05517980
What this trial is testing

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Who this might be right for
Glomerulonephritis
Kira Pharmacenticals (US), LLC. 52
Testing effectiveness (Phase 2)Study completedNCT03030183
What this trial is testing

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ra Pharmaceuticals 3
Early research (Phase 1)Study completedNCT03405441
What this trial is testing

Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 42
Early research (Phase 1)Study completedNCT04232345
What this trial is testing

Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT04525131
What this trial is testing

Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors

Who this might be right for
Bladder Cancer
CicloMed LLC 12
Early research (Phase 1)UnknownNCT05781386
What this trial is testing

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

Who this might be right for
Advanced Solid TumorCutaneous T Cell Lymphoma
Jiangsu Simcere Biologics Co., Ltd 255
Early research (Phase 1)Ended earlyNCT03166631
What this trial is testing

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

Who this might be right for
NeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 62
Early research (Phase 1)Study completedNCT06037395
What this trial is testing

Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Who this might be right for
Healthy Subject
Celltrion 154
Early research (Phase 1)Active Not RecruitingNCT07551505
What this trial is testing

Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)

Who this might be right for
Dyslipidemias
Bisirna Therapeutics (Suzhou) Co., Ltd. 40
Next Page